EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours

Alexandra Leary, Ana Oaknin, José Manuel Trigo, Victor Moreno, Jean-Pierre Delord, Valentina Boni, Irene Braña, Cristian Fernández, Carmen Kahatt, Antonio Nieto, Martin Cullell-Young, Ali Zeaiter und 1 weitere

European Journal of Cancer · 2023

DOI: 10.1016/j.ejca.2023.113259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2023. Verfasst von Alexandra Leary und 12 weiteren Autor:innen. Beteiligte Einrichtung: Gustave Roussy Cancer Campus, Villejuif, France. Hauptthemen laut MEDLINE: Lung Neoplasms, Neutropenia, Ovarian Neoplasms, Small Cell Lung Carcinoma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsNeutropeniaOvarian NeoplasmsSmall Cell Lung CarcinomaAdultFemaleHumansBRCA1 ProteinBRCA2 ProteinNeoplasm Recurrence, LocalClinical Trials, Phase II as TopicClinical Trials, Phase III as TopicRandomized Controlled Trials as TopicCarbolinesHeterocyclic Compounds, 4 or More Rings

Stichwörter der Autor:innen

LurbinectedinPhase IIPhase IIIPooled safety

Substanzen

BRCA1 ProteinBRCA2 ProteinBRCA1 protein, humanBRCA2 protein, humanPM 01183CarbolinesHeterocyclic Compounds, 4 or More Rings

Autor:innen und Institutionen

  • Gustave Roussy Cancer Campus, Villejuif, France.
  • Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), IOB-Quirón, UVic-UCC, Barcelona, Spain.
  • Hospital Universitario Virgen de la Victoria, Málaga, Spain.
  • START Madrid - FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
  • Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.
  • NEXT Madrid, Universitary Hospital QuironSalud Madrid, Madrid, Spain; START Madrid - HM CIOCC, Hospital Madrid Norte Sanchinarro, Madrid, Spain.

Zitieren

APA

Leary, A., Oaknin, A., Trigo, J. M., Moreno, V., Delord, J. P., Boni, V., Braña, I., Fernández, C., Kahatt, C., Nieto, A., Cullell-Young, M., Zeaiter, A., & Subbiah, V. (2023). Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.113259

Vancouver

Leary A, Oaknin A, Trigo JM, Moreno V, Delord JP, Boni V, et al. Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours. European Journal of Cancer. 2023. doi:10.1016/j.ejca.2023.113259

BibTeX
@article{Leary2023,
  author = {Leary, Alexandra and Oaknin, Ana and Trigo, José Manuel and Moreno, Victor and Delord, Jean-Pierre and Boni, Valentina and Braña, Irene and Fernández, Cristian and Kahatt, Carmen and Nieto, Antonio and Cullell-Young, Martin and Zeaiter, Ali and Subbiah, Vivek},
  title = {Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours},
  journal = {European Journal of Cancer},
  year = {2023},
  doi = {10.1016/j.ejca.2023.113259}
}
Kostenlos starten →